A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSRBin Ren, Roya Khosravi‐Far|Cancer Research|2009Cited by 52
Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor SuppressorsZainab Jagani, Roya Khosravi‐Far|Cancer Research|2009Cited by 48
A novel caspase 8 selective small molecule potentiates TRAIL-induced cell deathOctavian Bucur, Roya Khosravi‐Far|Scientific Reports|2015Cited by 28
Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic CellsOctavian Bucur, Roya Khosravi‐Far|PLoS ONE|2013Cited by 24
killerFLIP: a novel lytic peptide specifically inducing cancer cell deathBodvaël Pennarun, Roya Khosravi‐Far|Cell Death and Disease|2013Cited by 17